Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1992-8-3
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0004-3591
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
842-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1622426-Administration, Oral,
pubmed-meshheading:1622426-Allopurinol,
pubmed-meshheading:1622426-Clinical Protocols,
pubmed-meshheading:1622426-Desensitization, Immunologic,
pubmed-meshheading:1622426-Humans,
pubmed-meshheading:1622426-Injections, Intravenous,
pubmed-meshheading:1622426-Male,
pubmed-meshheading:1622426-Middle Aged
|
pubmed:year |
1992
|
pubmed:articleTitle |
Pharmacologic desensitization by intravenous protocols.
|
pubmed:publicationType |
Letter,
Comment,
Case Reports
|